Scientists have created a new light-based cancer therapy that targets tumors precisely without harming healthy cells.
DermaSensor announced today that it raised $16 million in a Series B funding round to fuel its commercial expansion efforts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback